A small number of early introductions seeded widespread transmission of SARS-CoV-2 in Québec, Canada.


Journal

Genome medicine
ISSN: 1756-994X
Titre abrégé: Genome Med
Pays: England
ID NLM: 101475844

Informations de publication

Date de publication:
28 10 2021
Historique:
received: 14 04 2021
accepted: 05 10 2021
entrez: 28 10 2021
pubmed: 29 10 2021
medline: 3 11 2021
Statut: epublish

Résumé

Québec was the Canadian province most impacted by COVID-19, with 401,462 cases as of September 24th, 2021, and 11,347 deaths due mostly to a very severe first pandemic wave. In April 2020, we assembled the Coronavirus Sequencing in Québec (CoVSeQ) consortium to sequence SARS-CoV-2 genomes in Québec to track viral introduction events and transmission within the province. Using genomic epidemiology, we investigated the arrival of SARS-CoV-2 to Québec. We report 2921 high-quality SARS-CoV-2 genomes in the context of > 12,000 publicly available genomes sampled globally over the first pandemic wave (up to June 1st, 2020). By combining phylogenetic and phylodynamic analyses with epidemiological data, we quantify the number of introduction events into Québec, identify their origins, and characterize the spatiotemporal spread of the virus. Conservatively, we estimated approximately 600 independent introduction events, the majority of which happened from spring break until 2 weeks after the Canadian border closed for non-essential travel. Subsequent mass repatriations did not generate large transmission lineages (> 50 sequenced cases), likely due to mandatory quarantine measures in place at the time. Consistent with common spring break and "snowbird" destinations, most of the introductions were inferred to have originated from Europe via the Americas. Once introduced into Québec, viral lineage sizes were overdispersed, with a few lineages giving rise to most infections. Consistent with founder effects, the earliest lineages to arrive tended to spread most successfully. Fewer than 100 viral introductions arrived during spring break, of which 7-12 led to the largest transmission lineages of the first wave (accounting for 52-75% of all sequenced infections). These successful transmission lineages dispersed widely across the province. Transmission lineage size was greatly reduced after March 11th, when a quarantine order for returning travellers was enacted. While this suggests the effectiveness of early public health measures, the biggest transmission lineages had already been ignited prior to this order. Combined, our results reinforce how, in the absence of tight travel restrictions or quarantine measures, fewer than 100 viral introductions in a week can ensure the establishment of extended transmission chains.

Sections du résumé

BACKGROUND
Québec was the Canadian province most impacted by COVID-19, with 401,462 cases as of September 24th, 2021, and 11,347 deaths due mostly to a very severe first pandemic wave. In April 2020, we assembled the Coronavirus Sequencing in Québec (CoVSeQ) consortium to sequence SARS-CoV-2 genomes in Québec to track viral introduction events and transmission within the province.
METHODS
Using genomic epidemiology, we investigated the arrival of SARS-CoV-2 to Québec. We report 2921 high-quality SARS-CoV-2 genomes in the context of > 12,000 publicly available genomes sampled globally over the first pandemic wave (up to June 1st, 2020). By combining phylogenetic and phylodynamic analyses with epidemiological data, we quantify the number of introduction events into Québec, identify their origins, and characterize the spatiotemporal spread of the virus.
RESULTS
Conservatively, we estimated approximately 600 independent introduction events, the majority of which happened from spring break until 2 weeks after the Canadian border closed for non-essential travel. Subsequent mass repatriations did not generate large transmission lineages (> 50 sequenced cases), likely due to mandatory quarantine measures in place at the time. Consistent with common spring break and "snowbird" destinations, most of the introductions were inferred to have originated from Europe via the Americas. Once introduced into Québec, viral lineage sizes were overdispersed, with a few lineages giving rise to most infections. Consistent with founder effects, the earliest lineages to arrive tended to spread most successfully. Fewer than 100 viral introductions arrived during spring break, of which 7-12 led to the largest transmission lineages of the first wave (accounting for 52-75% of all sequenced infections). These successful transmission lineages dispersed widely across the province. Transmission lineage size was greatly reduced after March 11th, when a quarantine order for returning travellers was enacted. While this suggests the effectiveness of early public health measures, the biggest transmission lineages had already been ignited prior to this order.
CONCLUSIONS
Combined, our results reinforce how, in the absence of tight travel restrictions or quarantine measures, fewer than 100 viral introductions in a week can ensure the establishment of extended transmission chains.

Identifiants

pubmed: 34706766
doi: 10.1186/s13073-021-00986-9
pii: 10.1186/s13073-021-00986-9
pmc: PMC8550813
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

169

Informations de copyright

© 2021. The Author(s).

Références

Mol Biol Evol. 2008 Jun;25(6):1007-15
pubmed: 18195052
Cell. 2021 Jan 7;184(1):64-75.e11
pubmed: 33275900
Science. 2020 Oct 30;370(6516):564-570
pubmed: 32912998
Int J Infect Dis. 2021 Jan;102:254-259
pubmed: 33115683
Curr Protoc Bioinformatics. 2020 Mar;69(1):e96
pubmed: 32162851
Science. 2021 Jan 29;371(6528):466-467
pubmed: 33510015
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Nat Microbiol. 2021 Jan;6(1):112-122
pubmed: 33349681
Genome Biol. 2019 Jan 8;20(1):8
pubmed: 30621750
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242
Bioinformatics. 2015 Jun 15;31(12):2032-4
pubmed: 25697820
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Virus Evol. 2018 Jan 08;4(1):vex042
pubmed: 29340210
PLoS Comput Biol. 2019 Apr 8;15(4):e1006650
pubmed: 30958812
J Theor Biol. 2012 Dec 7;314:204-15
pubmed: 22940235
J Open Source Softw. 2021;6(57):
pubmed: 34189396
Science. 2020 Jul 17;369(6501):297-301
pubmed: 32471856
Bioinformatics. 2019 Feb 1;35(3):526-528
pubmed: 30016406
Gigascience. 2021 Feb 16;10(2):
pubmed: 33590861
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
Nature. 2021 Apr;592(7852):122-127
pubmed: 33636719
Science. 2021 Feb 12;371(6530):708-712
pubmed: 33419936
Genome Biol. 2020 Dec 23;21(1):304
pubmed: 33357233
J Theor Biol. 2006 Mar 21;239(2):226-35
pubmed: 16239014
Virus Evol. 2020 Aug 19;6(2):veaa061
pubmed: 33235813
Nat Commun. 2021 Jan 28;12(1):649
pubmed: 33510171
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Mol Biol Evol. 2020 Feb 1;37(2):599-603
pubmed: 31633786
Epidemics. 2017 Dec;21:21-29
pubmed: 28552262
Genome Biol. 2019 Jun 24;20(1):129
pubmed: 31234903
Virus Evol. 2016 Apr 09;2(1):vew007
pubmed: 27774300
Nat Methods. 2015 Aug;12(8):733-5
pubmed: 26076426
Bioinformatics. 2011 Feb 15;27(4):592-3
pubmed: 21169378
Cell. 2020 Aug 20;182(4):794-795
pubmed: 32697970
Science. 2021 Feb 5;371(6529):
pubmed: 33303686
Genetics. 1989 Nov;123(3):585-95
pubmed: 2513255
Science. 2020 Oct 30;370(6516):571-575
pubmed: 32913002
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
J Clin Virol. 2020 Jul;128:104433
pubmed: 32405254

Auteurs

Carmen Lía Murall (CL)

McGill Genome Centre, Montreal, QC, Canada.
Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada.
Département de Sciences Biologiques, Université de Montréal, Montreal, QC, Canada.

Eric Fournier (E)

Laboratoire de Santé Publique du Québec, Institut National de Santé Publique, Montreal, QC, Canada.

Jose Hector Galvez (JH)

McGill Genome Centre, Montreal, QC, Canada.
Canadian Center for Computational Genomics, Montreal, QC, Canada.

Arnaud N'Guessan (A)

Département de Sciences Biologiques, Université de Montréal, Montreal, QC, Canada.

Sarah J Reiling (SJ)

McGill Genome Centre, Montreal, QC, Canada.
Department of Human Genetics, McGill University, Montreal, QC, Canada.

Pierre-Olivier Quirion (PO)

McGill Genome Centre, Montreal, QC, Canada.
Canadian Center for Computational Genomics, Montreal, QC, Canada.
Calcul Québec, Montreal, QC, Canada.

Sana Naderi (S)

McGill Genome Centre, Montreal, QC, Canada.
Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada.

Anne-Marie Roy (AM)

McGill Genome Centre, Montreal, QC, Canada.
Department of Human Genetics, McGill University, Montreal, QC, Canada.

Shu-Huang Chen (SH)

McGill Genome Centre, Montreal, QC, Canada.
Department of Human Genetics, McGill University, Montreal, QC, Canada.

Paul Stretenowich (P)

McGill Genome Centre, Montreal, QC, Canada.
Canadian Center for Computational Genomics, Montreal, QC, Canada.

Mathieu Bourgey (M)

McGill Genome Centre, Montreal, QC, Canada.
Canadian Center for Computational Genomics, Montreal, QC, Canada.

David Bujold (D)

McGill Genome Centre, Montreal, QC, Canada.
Canadian Center for Computational Genomics, Montreal, QC, Canada.

Romain Gregoire (R)

McGill Genome Centre, Montreal, QC, Canada.
Canadian Center for Computational Genomics, Montreal, QC, Canada.

Pierre Lepage (P)

McGill Genome Centre, Montreal, QC, Canada.

Janick St-Cyr (J)

McGill Genome Centre, Montreal, QC, Canada.

Patrick Willet (P)

McGill Genome Centre, Montreal, QC, Canada.

Réjean Dion (R)

Laboratoire de Santé Publique du Québec, Institut National de Santé Publique, Montreal, QC, Canada.
Ecole de santé publique, Université de Montréal, Montreal, QC, Canada.

Hugues Charest (H)

Laboratoire de Santé Publique du Québec, Institut National de Santé Publique, Montreal, QC, Canada.

Mark Lathrop (M)

McGill Genome Centre, Montreal, QC, Canada.
Department of Human Genetics, McGill University, Montreal, QC, Canada.

Michel Roger (M)

Laboratoire de Santé Publique du Québec, Institut National de Santé Publique, Montreal, QC, Canada.
Département de Microbiologie, infectiologie et Immunologie, Université de Montréal, Montreal, QC, Canada.

Guillaume Bourque (G)

McGill Genome Centre, Montreal, QC, Canada.
Canadian Center for Computational Genomics, Montreal, QC, Canada.
Department of Human Genetics, McGill University, Montreal, QC, Canada.

Jiannis Ragoussis (J)

McGill Genome Centre, Montreal, QC, Canada.
Department of Human Genetics, McGill University, Montreal, QC, Canada.
Department of Bioengineering, McGill University, Montreal, QC, Canada.

B Jesse Shapiro (BJ)

McGill Genome Centre, Montreal, QC, Canada. jesse.shapiro@mcgill.ca.
Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada. jesse.shapiro@mcgill.ca.
Département de Sciences Biologiques, Université de Montréal, Montreal, QC, Canada. jesse.shapiro@mcgill.ca.

Sandrine Moreira (S)

Laboratoire de Santé Publique du Québec, Institut National de Santé Publique, Montreal, QC, Canada.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH